295 related articles for article (PubMed ID: 26418614)
1. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.
Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW
Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767
[TBL] [Abstract][Full Text] [Related]
3. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
5. Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
Weis J; von Below C; Tolf A; Ortiz-Nieto F; Wassberg C; Häggman M; Ladjevardi S; Ahlström H
J Magn Reson Imaging; 2017 Apr; 45(4):1232-1240. PubMed ID: 27556571
[TBL] [Abstract][Full Text] [Related]
6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
7. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Zakian KL; Eberhardt S; Hricak H; Shukla-Dave A; Kleinman S; Muruganandham M; Sircar K; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
[TBL] [Abstract][Full Text] [Related]
8. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
9. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
[TBL] [Abstract][Full Text] [Related]
10. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
[TBL] [Abstract][Full Text] [Related]
11. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
[TBL] [Abstract][Full Text] [Related]
14. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
[TBL] [Abstract][Full Text] [Related]
15. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
[TBL] [Abstract][Full Text] [Related]
16. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
Nagarajan R; Gomez AM; Raman SS; Margolis DJ; McClure T; Thomas MA
NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
[TBL] [Abstract][Full Text] [Related]
17. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
Zakian KL; Sircar K; Hricak H; Chen HN; Shukla-Dave A; Eberhardt S; Muruganandham M; Ebora L; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
Radiology; 2005 Mar; 234(3):804-14. PubMed ID: 15734935
[TBL] [Abstract][Full Text] [Related]
18. Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study.
Hectors SJ; Semaan S; Song C; Lewis S; Haines GK; Tewari A; Rastinehad AR; Taouli B
Radiology; 2018 Mar; 286(3):918-928. PubMed ID: 29117481
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
